Glycosylation modulates TRAIL-R1/death receptor 4 protein: Different regulations of two pro-apoptotic receptors for TRAIL by tunicamycin

Oncology Reports

Volumn 18, Issue 5, 2007, Pages 1239-1242

  Yoshida, Tatsushi ^a   Shiraishi, Takumi ^a   Horinaka, Mano ^a   Wakada, Miki ^a   Sakai, Toshiyuki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

DR4; DR5; Glycosylation; TRAIL; Tunicamycin

Indexed keywords

ANTIVIRUS AGENT; BREFELDIN A; ENZYME INHIBITOR; SMALL INTERFERING RNA; THAPSIGARGIN; TNFRSF10A PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; TUNICAMYCIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; GLYCOSYLATION; HUMAN; MALE; METABOLISM; WESTERN BLOTTING;

ANTIVIRAL AGENTS; APOPTOSIS; BLOTTING, WESTERN; BREFELDIN A; ENZYME INHIBITORS; GLYCOSYLATION; HUMANS; MALE; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, SMALL INTERFERING; THAPSIGARGIN; TUMOR CELLS, CULTURED; TUNICAMYCIN;

EID: 38449118214     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.5.1239     Document Type: Article

References (28)

1. Wiley SR, Schooley K, Smolak PJ, et al: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682, 1995. (Pubitemid 26091143)
2. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A and Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271: 12687-12690, 1996. (Pubitemid 26175834)
3. Walczak H, Miller RE, Ariail K, et al: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5: 157-163, 1999. (Pubitemid 29068521)
4. Ashkenazi A, Pai RC, Fong S, et al: Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155-162, 1999.
5. Lawrence D, Shahrokh Z, Marsters S, et al: Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med 7: 383-385, 2001.
6. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J and Dixit VM: The receptor for the cytotoxic ligand TRAIL. Science 276: 111-113, 1997. (Pubitemid 27161256)
7. Pan G, Ni J, Wei Y-F, Yu G-L, Gentz R and Dixit VM: An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277: 815-818, 1997. (Pubitemid 27366732)
8. Sheridan JP, Marsters SA, Pitti RM, et al: Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818-821, 1997. (Pubitemid 27366733)
9. Le Blanc HN and Ashkenazi A: Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 10: 66-75, 2003. (Pubitemid 36511833)
10. Sprick MR, Weigand MA, Rieser E, et al: FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12: 599-609, 2000.
11. Ichikawa K, Liu W, Zhao L, et al: Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med 7: 954-960, 2001. (Pubitemid 32756434)
12. Pukac L, Kanakaraj P, Humphreys R, et al: HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo. Br J Cancer 92: 1430-1441, 2005. (Pubitemid 40705010)
13. Fesik SW: Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5: 876-885, 2005.
14. Helenius A and Aebi M: Intracellular functions of N-linked glycans. Science 291: 2364-2369, 2001. (Pubitemid 32231791)
15. Wu JJ, Choi LE and Guidotti G: N-linked oligosaccharides affect the enzymatic activity of CD39: diverse interactions between seven N-linked glycosylation sites. Mol Biol Cell 16: 1661-1672, 2005. (Pubitemid 40471938)
16. Ding DX, Vera JC, Heaney ML and Golde DW: N-glycosylation of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit is essential for ligand binding and signal transduction. J Biol Chem 270: 24580-24584, 1995.
17. Shields RL, Lai J, Keck R, et al: Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fc γ RIII and antibody-dependent cellular toxicity. J Biol Chem 277: 26733-26740, 2002. (Pubitemid 34951677)
18. Elbein AD: Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu Rev Biochem 56: 497-534, 1987.
19. Shiraishi T, Yoshida T, Nakata S, et al: Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Cancer Res 65: 6364-6370, 2005. (Pubitemid 40994423)
20. Nakata S, Yoshida T, Horinaka M, Shiraishi T, Wakada M and Sakai T: Histone deacetylase inhibitors up-regulate death receptor 5/TRAIL-R2, and sensitize apoptosis induced by TRAIL/APO2-L in human malignant tumor cells. Oncogene 23: 6261-6271, 2004. (Pubitemid 39215296)
21. Wang S and El-Deiry WS: Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil. Cancer Res 64: 6666-6672, 2004. (Pubitemid 39297928)
22. Ren YG, Wagner KW, Knee DA, Aza-Blanc P, Nasoff M and Deveraux QL: Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle. Mol Biol Cell 15: 5064-5074, 2004. (Pubitemid 39392220)
23. 2+ transport ATPase by thapsigargin at subnanomolar concentrations. J Biol Chem 266: 13503-13506, 1991.
24. Kain SR, Platt EJ, Brown KS, Black N and Firestone GL: Disruptions in intracellular membrane trafficking and structure preclude the glucocorticoid-dependent maturation of mouse mammary tumor virus proteins in rat hepatoma cells. J Biol Chem 267: 8128-8135, 1992.
25. Yoshida T, Maeda A, Tani N and Sakai T: Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL-R2 gene. FEBS Lett 507: 381-385, 2001. (Pubitemid 33030270)
26. Yoshida T and Sakai T: Promoter of TRAIL-R2 gene. Vitam Horm 67: 35-49, 2004. (Pubitemid 39753659)
27. Higuchi H, Bronk SF, Takikawa Y, Werneburg N, Takimoto R, El-Deiry W and Gores GJ: The bile acid glycochenodeoxycholate induces TRAIL-receptor 2/DR5 expression and apoptosis. J Biol Chem 276: 38610-38618, 2001.
28. Branza-Nichita N, Negroiu G, Petrescu AJ, et al: Mutations at critical N-glycosylation sites reduce tyrosinase activity by altering folding and quality control. J. Biol Chem 275: 8169-8175, 2000. (Pubitemid 30159732)